SAN DIEGO, Dec. 23, 2024 /PRNewswire/ -- Nuvve Holding Corp.  (Nasdaq: NVVE) ("Nuvve" or "the Company") would like its shareholders to vote in its upcoming Special Meeting of Stockholders ("Special Meeting") on January 13, 2025 at 1:00 p.m. Eastern (10:00 am Pacific) Time.  The methods for voting and submitting proxies are described in the distributed proxy materials for the Special Meeting.

The record date for the Special Meeting is December 6, 2024. For assistance with voting your shares, please contact Advantage Proxy, Inc. toll-free at 1-877-870-8565 or by e-mail at This email address is being protected from spambots. You need JavaScript enabled to view it..

Nuvve asks that all shareholders vote their proxy, no matter how many shares they own. Nuvve strongly encourages all its shareholders to read the company's definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission (the "SEC") on December 16, 2024 (the "Proxy Statement"), which are available free of charge on the SEC's website at www.sec.gov.

About Nuvve

Nuvve (Nasdaq: NVVE) is a global technology leader accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) platform. Nuvve's mission is to lower the cost of electric vehicle ownership while supporting the integration of renewable energy sources, including solar and wind. For more information, please visit nuvve.com.

Nuvve Investor Contact

This email address is being protected from spambots. You need JavaScript enabled to view it. 
+1 (619) 483-3448

Nuvve Press Contacts

This email address is being protected from spambots. You need JavaScript enabled to view it. 
+1 (619) 483-3448

Nuvve Forward Looking Statements

This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "aims," "anticipates," "plans," "looking forward to," "estimates," "projects," "assumes," "guides," "targets," "forecasts," "continue," "seeks" or the negatives of such terms or other variations on such terms or comparable terminology, although not all forward-looking statements contain such identifying words. Forward-looking statements include, but are not limited to, statements concerning the Company's expectations, plans, intentions, strategies, prospects, business plans, product and service offerings, new product launches, potential clinical successes, and other statements that are not historical facts. Nuvve cautions you that these forward-looking statements are subject to numerous risks and uncertainties, most of which are difficult to predict and many of which are beyond the control of Nuvve. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks and uncertainties that could cause actual outcomes and results to differ materially. Some of these risks and uncertainties can be found in Nuvve's most recent Annual Report on Form 10-K and subsequent periodic reports filed with the Securities and Exchange Commission (SEC). Copies of these filings are available online at www.sec.gov, http://investors.nuvve.com/ or on request from Nuvve. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in the Nuvve's filings with the SEC. Such forward-looking statements speak only as of the date made, and Nuvve disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers of this press release are cautioned not to place undue reliance on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this press release.